Greenwich LifeSciences

$5.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+2.21%) As of 4:14 PM UTC today

Why Robinhood?

You can buy or sell GLSI and other stocks, options, and ETFs commission-free!

About GLSI

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX. The listed name for GLSI is Greenwich LifeSciences, Inc. Common Stock.

CEO
Snehal Patel
Employees
Headquarters
Stafford, Texas
Founded
2006
Market Cap
67.91M
Price-Earnings Ratio
Dividend Yield
Average Volume
48.94K
High Today
$5.80
Low Today
$5.35
Open Price
$5.47
Volume
33.88K
52 Week High
$5.80
52 Week Low
$3.26

Collections

GLSI Earnings

Q3 FY20
Estimated
per share
Actual
Expected Dec 15, Pre-Market

You May Also Like